Skip to content

EFFECT

Efficacy and safety study of atrial fibrillation prevention on AF burden reduction for bradycardia-tachycardia syndrome patients with atrial fibrillation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001217
Enrollment
Unknown
Registered
2011-03-06
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal atrial fibrillation

Interventions

Group A:Random PPTs ON 6month
Group B:Random PPTs OFF 6month

Sponsors

Hangzhou First People's Hospital, Hangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Have indications for Class I or Class II dual-chamber; 2. With at least one episode of atrial fibrillation within 12 months before inclusion; 3. Have stable residence, with good compliance for clinical follow-up; 4. Sign consent form and indicate the date

Exclusion criteria

Exclusion criteria: 1. Persistent or permanent atrial fibrillation; 2. Atrial fibrillation by reversible causes; 3. Treated by cardioversion within 6 months before inclusion; ; 4. Plan to receive AF ablation; 5. Plan to receive ICD implantation who had undergone cardiothoracic surgery; 6. NYHA III or IV; 7. Life expectancy = 2 years; 8. Participate in other clinical studies that might affect the results of this study; 9. Do not agree on the participation, or do not sign informed consent forms; 10. With class IIb or III indications according to ACC / AHA / HRS permanent pacemaker guidelines; 11. With other physical disorders that do not meet the requirements of the study; 12. Pregnant women or women that plan to get pregnant during the study period.

Design outcomes

Primary

MeasureTime frame
AFburden;

Countries

China

Contacts

Public ContactFeng LIN
lingfeng41402@163.com+86 57187065701-21683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026